{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Red+Man+Syndrome", "query": { "condition": "Red Man Syndrome" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T23:08:29.846Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00061763", "title": "Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Beta-thalassemia", "Myelodysplastic Syndromes", "Fanconi Syndrome", "Anemia, Diamond-Blackfan", "Anemia, Aplastic" ], "interventions": [ { "name": "Deferasirox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 175, "start_date": "2003-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 6, "location_summary": "Oakland, California • Stanford, California • Arlington Heights, Illinois + 3 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061763" }, { "nct_id": "NCT01586455", "title": "Human Placental-Derived Stem Cell Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Mucopolysaccharidosis I", "Mucopolysaccharidosis VI", "Adrenoleukodystrophy", "Niemann-Pick Disease", "Metachromatic Leukodystrophy", "Wolman Disease", "Krabbe's Disease", "Gaucher's Disease", "Fucosidosis", "Batten Disease", "Severe Aplastic Anemia", "Diamond-Blackfan Anemia", "Amegakaryocytic Thrombocytopenia", "Myelodysplastic Syndrome", "Acute Myelogenous Leukemia", "Acute Lymphocytic Leukemia" ], "interventions": [ { "name": "Human Placental Derived Stem Cell", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York Medical College", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "0 Years to 55 Years" }, "enrollment_count": 43, "start_date": "2013-04", "completion_date": "2022-09", "has_results": false, "last_update_posted_date": "2022-10-25", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 3, "location_summary": "Denver, Colorado • Valhalla, New York • Salt Lake City, Utah", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Valhalla", "state": "New York" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01586455" }, { "nct_id": "NCT03513328", "title": "Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bone Marrow Failure Syndrome", "Thalassemia", "Sickle Cell Disease", "Diamond Blackfan Anemia", "Acquired Neutropenia in Newborn", "Acquired Anemia Hemolytic", "Acquired Thrombocytopenia", "Hemophagocytic Lymphohistiocytoses", "Wiskott-Aldrich Syndrome", "Chronic Granulomatous Disease", "Common Variable Immunodeficiency", "X-linked Lymphoproliferative Disease", "Severe Combined Immunodeficiency", "Hurler Syndrome", "Mannosidosis", "Adrenoleukodystrophy" ], "interventions": [ { "name": "Thiotepa--single daily dose", "type": "DRUG" }, { "name": "Thiotepa--escalated dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "39 Years", "sex": "ALL", "summary": "3 Months to 39 Years" }, "enrollment_count": 6, "start_date": "2018-06-15", "completion_date": "2023-02-19", "has_results": true, "last_update_posted_date": "2023-09-15", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03513328" }, { "nct_id": "NCT00824122", "title": "Vancomycin Associated Red Man Syndrome (RMS)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Red Man Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Mercy Hospital Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "21 Years", "sex": "ALL", "summary": "6 Months to 21 Years" }, "enrollment_count": 544, "start_date": "2008-01", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2011-10-12", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00824122" }, { "nct_id": "NCT01758042", "title": "Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Kidney Disease", "Acute Myeloid Leukemia (AML)", "Acute Lymphoblastic Leukemia (ALL)", "Chronic Myelogenous Leukemia (CML)", "Chronic Lymphocytic Leukemia (CLL)", "Non-Hodgkin's Lymphoma (NHL)", "Hodgkin Disease", "Multiple Myeloma", "Myelodysplastic Syndrome (MDS)", "Aplastic Anemia", "AL Amyloidosis", "Diamond Blackfan Anemia", "Myelofibrosis", "Myeloproliferative Disease", "Sickle Cell Anemia", "Autoimmune Diseases", "Thalassemia" ], "interventions": [ { "name": "Haploidentical Bone Marrow/Kidney", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2012-11", "completion_date": "2025-07", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01758042" }, { "nct_id": "NCT05635266", "title": "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet's Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo" ], "interventions": [ { "name": "Specimen sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20000, "start_date": "2021-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-09-03T23:08:29.846Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635266" } ] }